Abstract:Background Early identification of Alzheimer’s disease or mild cognitive impairment can help guide direct prevention and supportive treatments, improve outcomes, and reduce medical costs. Existing advanced diagnostic tools are mostly based on neuroimaging and suffer from certain problems in cost, reliability, repeatability, accessibility, ease of use, and clinical integration. To address these problems, we developed, evaluated, and implemented an early diagnostic tool using machine learning and non-imaging factors. Methods and results A total of 654 participants aged 65 or older from the Nursing Home in Hangzhou, China were identified. Information collected from these patients includes dementia status and 70 demographic, cognitive, socioeconomic, and clinical features. Logistic regression, support vector machine (SVM), neural network, random forest, extreme gradient boosting (XGBoost), least absolute shrinkage and selection operator (LASSO), and best subset models were trained, tuned, and internally validated using a novel double cross validation algorithm and multiple evaluation metrics. The trained models were also compared and externally validated using a separate dataset with 1,100 participants from four communities in Zhejiang Province, China. The model with the best performance was then identified and implemented online with a friendly user interface. For the nursing dataset, the top three models are the neural network (AUROC = 0.9435), XGBoost (AUROC = 0.9398), and SVM with the polynomial kernel (AUROC = 0.9213). With the community dataset, the best three models are the random forest (AUROC = 0.9259), SVM with linear kernel (AUROC = 0.9282), and SVM with polynomial kernel (AUROC = 0.9213). The F1 scores and area under the precision-recall curve showed that the SVMs, neural network, and random forest were robust on the unbalanced community dataset. Overall the SVM with the polynomial kernel was found to be the best model. The LASSO and best subset models identified 17 features most relevant to dementia prediction, mostly from cognitive test results and socioeconomic characteristics. Conclusion Our non-imaging-based diagnostic tool can effectively predict dementia outcomes. The tool can be conveniently incorporated into clinical practice. Its online implementation allows zero barriers to its use, which enhances the disease’s diagnosis, improves the quality of care, and reduces costs.

Computerized decision support to optimally funnel patients through the diagnostic pathway for dementia

Computerized decision support is an effective approach to select memory clinic patients for amyloid-PET

Use of a digital tool to support the diagnostic process in memory clinics–a usability study

A practical computerized decision support system for predicting the severity of Alzheimer's disease of an individual

Why to test for dementia: perspectives of patients, significant others and general practitioners

Computer-aided diagnosis and prediction in brain disorders

Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice

The Association of Ancillary Diagnostic Tests With Outcome in Dementia

Pathways to Care for People with Dementia: an International Multicentre Study.

Develop a Diagnostic Tool for Dementia Using Machine Learning and Non-Imaging Features

Doing the Right Thing? General Practitioners' Considerations in Achieving a Timely Dementia Diagnosis

Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer’s disease

The Digitized Memory Clinic

Breaking barriers: a statistical and machine learning-based hybrid system for predicting dementia

Cascaded Multimodal Deep Learning in the Differential Diagnosis, Progression Prediction, and Staging of Alzheimer's and Frontotemporal Dementia

Documentation of shared decision-making in diagnostic testing for dementia in Dutch general practice: A retrospective study in electronic patient records

The expectations and experiences of patients regarding the diagnostic workup at a specialized memory clinic: An interview study

Supportive care decision-making processes of persons with dementia and their caregivers

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

Optimising Alzheimer’s Disease Diagnosis and Treatment: Assessing Cost-Utility of Integrating Blood Biomarkers in Clinical Practice for Disease-Modifying Treatment

Designing the Next-Generation Clinical Care Pathway for Alzheimer’s Disease